Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
Clinical trial NCT03474744 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03474744
- Sponsor
- Christian Buske
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-15
- Primary completion
- 2027-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.